Claudiu Morgovan – „Elemente de marketing în clasa medicamentelor antidiabetice”, Ed. Napoca Star, Cluj-Napoca, 2012, ISBN 978-973-647-954-0

Claudiu Morgovan – „Analiza pieţei medicamentelor antidiabetice. Strategii de marketing”, Ed. Napoca Star, Cluj-Napoca, 2012, ISBN 978-973-647-953-3

Neli Kinga Olah, Claudia Crina Toma, Claudiu Morgovan – „Teste grilă de licenţă pentru specializarea Farmacie ediţia a III-a revizuită”, Ed. Vasile Goldiş University Press, Arad, ISBN 978-973-664-865-6

Claudiu Morgovan, Claudia Crina Toma, Neli Kinga Olah – „Teste grilă de admitere pentru specializările: Farmacie / Nutriţie şi dietetică”, Ed. Vasile Goldiş University Press, Arad, 2016, ISBN: 978-973-664-812-0

Felicia Gabriela Gligor (coord.) – „Farmacie – Teste grilă pentru examenul de licență”, Ed. ULBS, 2022

D2. Morgovan, C.; Frum, A.; Stoicescu, L.; Butuca, A.; Dobrea, C.M.; Arseniu, A.M.; Chis, A.A.; Muresan, M.L.; Gligor, F.G.; Popa Ilie, I.R.; et al. An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives. Pharmaceutics 2026, 18, 163. https://doi.org/10.3390/pharmaceutics18020163

D13. Popa Ilie, I.R.; Vonica-Tincu, A.L.; Dobrea, C.M.; Butuca, A.; Frum, A.; Morgovan, C.; Gligor, F.G.; Ghibu, S. Safety Profiles Related to Dosing Errors of Rapid-Acting Insulin Analogs: A Comparative Analysis Using the EudraVigilance Database. Biomedicines 2024, 12, 2273. https://doi.org/10.3390/biomedicines12102273

D17. Butuca, A.; Dobrea, C.M.; Arseniu, A.M.; Frum, A.; Chis, A.A.; Rus, L.L.; Ghibu, S.; Juncan, A.M.; Muntean, A.C.; Lazăr, A.E., Gligor F.G., Morgovan C., Vonica-Ţincu L.A.; An Assessment of Semaglutide Safety Based on Real World Data: From Popularity to Spontaneous Reporting in EudraVigilance Database. Biomedicines 2024, 12, 1124. https://doi.org/10.3390/biomedicines12051124

D18. Morgovan, C.; Dobrea, C.M.; Butuca, A.; Arseniu, A.M.; Frum, A.; Rus, L.L.; Chis, A.A.; Juncan, A.M.; Gligor, F.G.; Georgescu, C.; et al. Safety Profile of the Trastuzumab-Based ADCs: Analysis of Real-World Data Registered in EudraVigilance. Biomedicines 2024, 12, 953. https://doi.org/10.3390/biomedicines12050953

D19. Stoicescu, L.; Crişan, D.; Morgovan, C.; Avram, L.; Ghibu, S. Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach. Int. J. Mol. Sci. 2024, 25, 794. . https://doi.org/10.3390/ijms25020794

D21. Vintila, B.I.; Arseniu, A.M.; Morgovan, C.; Butuca, A.; Bîrluțiu, V.; Dobrea, C.M.; Rus, L.L.; Ghibu, S.; Bereanu, A.S.; Arseniu, R.; et al. A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and Clostridioides difficile Infection. Antibiotics 2024, 13, 144. https://doi.org/10.3390/antibiotics13020144

D25. Morgovan, C.; Dobrea, C.M.; Chis, A.A.; Juncan, A.M.; Arseniu, A.M.; Rus, L.L.; Gligor, F.G.; Ardelean, S.A.; Stoicescu, L.; Ghibu, S.; Frum, A. A Descriptive Analysis of Direct Oral Anticoagulant Drugs Dosing Errors Based on Spontaneous Reports from the EudraVigilance Database. Pharmaceuticals 2023, 16, 455. https://doi.org/10.3390/ph16030455

his, A.A.; Arseniu, A.M.; Morgovan, C.; Dobrea, C.M.; Frum, A.; Juncan, A.M.; Butuca, A.; Ghibu, S.; Gligor, F.G.; Rus, L.L. Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy. Pharmaceutics 2022, 14, 1773, , https://doi.org/10.3390/pharmaceutics14091773

D29. Chiș, A.A.; Rus, L.L.; Morgovan, C.; Arseniu, A.M.; Frum, A.; Vonica-Țincu, A.L.; Gligor, F.G.; Mureșan, M.L.; Dobrea, C.M. Microbial Resistance to Antibiotics and Effective Antibiotherapy. Biomedicines 2022, 10, 1121. https://doi.org/10.3390/biomedicines10051121

D30. Ghibu, S.; Juncan, A.M.; Rus, L.L.; Frum, A.; Dobrea, C.M.; Chiş, A.A.; Gligor, F.G.; Morgovan, C. The Particularities of Pharmaceutical Care in Improving Public Health Service During the COVID-19 Pandemic. Int. J. Environ. Res. Public Health 2021, 18, 9776

D31. Morgovan, C.; Cosma, S.A.; Valeanu, M.; Juncan, A.M.; Rus, L.L.; Gligor, F.G.; Butuca, A.; Tit, D.M.; Bungau, S.; Ghibu, S. An Exploratory Research of 18 Years on the Economic Burden of Diabetes for the Romanian National Health Insurance System. Int. J. Environ. Res. Public Health 2020, 17, 4456

D32. Pop, C.; Ștefan, M.-G.; Muntean, D.-M.; Stoicescu, L.; Gal, A.F.; Kiss, B.; Morgovan, C.; Loghin, F.; Rochette, L.; Lauzier, B.; Mogoșan, C.; Ghibu, S. Protective Effects of a Discontinuous Treatment with Alpha-Lipoic Acid in Obesity-Related Heart Failure with Preserved Ejection Fraction, in Rats. Antioxidants 2020, 9, 1073

D33. Ghibu Steliana, Craciun Cristina Elena, Rusu Razvan, Morgovan Claudiu, Mogosan Cristina, Rochette Luc, Gal Adrian Florin, Dronca Maria, Impact of Alpha-Lipoic Acid Chronic Discontinuous Treatment in Cardiometabolic Disorders and Oxidative Stress Induced by Fructose Intake in Rats. Antioxidants. 2019; 8(12):636, doi: antiox8120636

D41. Chis, A.A.; Dobrea, C.; Morgovan, C.; Arseniu, A.M.; Rus, L.L.; Butuca, A.; Juncan, A.M.; Totan, M.; Vonica-Tincu, A.L.; Cormos, G.; Muntean, A.C.; Muresan, M.L.; Gligor, F.G.; Frum, A. Applications and Limitations of Dendrimers in Biomedicine. Molecules 2020, 25, 3982.. doi.org/10.3390/molecules25173982

D42. Cosma, S.A.; Bota, M.; Fleșeriu, C.; Morgovan, C.; Văleanu, M.; Cosma, D. Measuring Patients’ Perception and Satisfaction with the Romanian Healthcare System. Sustainability 2020, 12, 1612, doi: 10.3390/su12041612,

D47. Claudiu Morgovan, Steliana Ghibu, Anca Maria Juncan, Luca Liviu Rus, Anca Butucă, Loredana Vonica, Andrei Muntean, Liana Moş, Felicia Gligor, Neli-Kinga Olah, Nutrivigilance: a new activity in the field of dietary supplements, Farmacia, 2019, 67(3): 537-544